ALNY » Topics » Stock Option Activity

This excerpt taken from the ALNY 10-K filed Feb 26, 2010.
Stock Option Activity
 
The following table summarizes the activity of the Company’s stock option plans:
 
                 
          Weighted
 
          Average
 
    Number of
    Exercise
 
    Options     Price  
 
Outstanding, December 31, 2008
    7,037,214     $ 19.87  
Granted
    1,650,088     $ 17.63  
Exercised
    (275,908 )   $ 5.30  
Cancelled
    (484,741 )   $ 27.52  
                 
Outstanding, December 31, 2009
    7,926,653     $ 19.44  
                 
Exercisable at December 31, 2007
    1,913,468     $ 7.49  
Exercisable at December 31, 2008
    2,903,479     $ 12.87  
Exercisable at December 31, 2009
    4,113,776     $ 17.14  
 
The weighted average remaining contractual life for options outstanding and exercisable at December 31, 2009 was 7.7 years and 6.6 years, respectively.
 
The aggregate intrinsic value of options outstanding at December 31, 2009 was $20.9 million, of which $19.2 million related to exercisable options. The intrinsic value of options exercised was $4.3 million, $8.2 million and $24.6 million for the years ended December 31, 2009, 2008 and 2007, respectively. The weighted average fair value of stock options granted was $9.84, $15.02 and $16.58 per share for the years ended December 31, 2009, 2008 and 2007, respectively.
 
The aggregate intrinsic value of options expected to vest at December 31, 2009 and 2008 was $1.6 million and $10.6 million, respectively. The weighted average fair value of stock options expected to vest was $12.56 and $12.10 per share as of December 31, 2009 and 2008, respectively. The weighted average remaining contractual life for options expected to vest at December 31, 2009 and 2008 was 8.3 years and 9.0 years, respectively, and the weighted average exercise price for these options was $21.92 and $24.76 per share on December 31, 2009 and 2008, respectively.
 
These excerpts taken from the ALNY 10-K filed Mar 2, 2009.
Stock Option Activity
 
The following table summarizes the activity of the Company’s stock option plans:
 
                 
          Weighted
 
          Average
 
    Number of
    Exercise
 
    Options     Price  
 
Outstanding, December 31, 2007
    5,304,021     $ 17.18  
Granted
    2,155,056     $ 24.87  
Exercised
    (377,228 )   $ 10.04  
Cancelled
    (44,635 )   $ 25.19  
                 
Outstanding, December 31, 2008
    7,037,214     $ 19.87  
                 
Exercisable at December 31, 2006
    1,953,502     $ 4.44  
Exercisable at December 31, 2007
    1,913,468     $ 7.49  
Exercisable at December 31, 2008
    2,903,479     $ 12.87  
 
The weighted average remaining contractual life for options outstanding and exercisable at December 31, 2008 was 8.1 years and 6.8 years, respectively.
 
The aggregate intrinsic value of outstanding options at December 31, 2008 was $48.3 million, of which $37.2 million related to exercisable options. The intrinsic value of options exercised was $8.2 million, $24.6 million and $7.6 million for the years ended December 31, 2008, 2007 and 2006, respectively. The weighted average fair value of stock options granted as part of the 2004 Plan was $15.02, $16.58 and $12.95 per share for the years ended December 31, 2008, 2007 and 2006, respectively.
 
The aggregate intrinsic value of options expected to vest at December 31, 2008 was $10.6 million. The weighted average fair value of stock options expected to vest as part of the 2004 Plan was $12.10 per share as of December 31, 2008. The weighted average remaining contractual life for options expected to vest at December 31, 2008 was 9.0 years and the weighted average exercise price for these options was $24.76 per share.


115


Table of Contents

 
ALNYLAM PHARMACEUTICALS, INC.
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
 
Stock
Option Activity



 



The following table summarizes the activity of the
Company’s stock option plans:


 





































































































































































                 

 

 

 

 

 

Weighted



 

 

 

 

 

 

Average



 

 

 

Number of



 

 

Exercise



 

 

 

Options

 

 

Price

 
 


Outstanding, December 31, 2007


 

 

5,304,021

 

 

$

17.18

 


Granted


 

 

2,155,056

 

 

$

24.87

 


Exercised


 

 

(377,228

)

 

$

10.04

 


Cancelled


 

 

(44,635

)

 

$

25.19

 

 

 

 

 

 

 

 

 

 


Outstanding, December 31, 2008


 

 

7,037,214

 

 

$

19.87

 

 

 

 

 

 

 

 

 

 


Exercisable at December 31, 2006


 

 

1,953,502

 

 

$

4.44

 


Exercisable at December 31, 2007


 

 

1,913,468

 

 

$

7.49

 


Exercisable at December 31, 2008


 

 

2,903,479

 

 

$

12.87

 






 



The weighted average remaining contractual life for options
outstanding and exercisable at December 31, 2008 was
8.1 years and 6.8 years, respectively.


 



The aggregate intrinsic value of outstanding options at
December 31, 2008 was $48.3 million, of which
$37.2 million related to exercisable options. The intrinsic
value of options exercised was $8.2 million,
$24.6 million and $7.6 million for the years ended
December 31, 2008, 2007 and 2006, respectively. The
weighted average fair value of stock options granted as part of
the 2004 Plan was $15.02, $16.58 and $12.95 per share for the
years ended December 31, 2008, 2007 and 2006, respectively.


 



The aggregate intrinsic value of options expected to vest at
December 31, 2008 was $10.6 million. The weighted
average fair value of stock options expected to vest as part of
the 2004 Plan was $12.10 per share as of December 31, 2008.
The weighted average remaining contractual life for options
expected to vest at December 31, 2008 was 9.0 years
and the weighted average exercise price for these options was
$24.76 per share.





115





Table of Contents





 




ALNYLAM
PHARMACEUTICALS, INC.




 




NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS —
(Continued)


 




These excerpts taken from the ALNY 10-K filed Mar 10, 2008.
Stock Option Activity
 
The following table summarizes the activity of the Company’s stock option plans:
 
                 
          Weighted
          Average
    Number of
    Exercise
    Options     Price
 
Outstanding, December 31, 2006
    4,649,959     $ 10 .03
Granted
    2,071,819     $ 27 .08
Exercised
    (1,247,808 )   $ 7 .39
Cancelled
    (169,949 )   $ 14 .05
                 
Outstanding, December 31, 2007
    5,304,021     $ 17 .18
                 
Exercisable at December 31, 2005
    1,550,510     $ 2 .54
Exercisable at December 31, 2006
    1,953,502     $ 4 .44
Exercisable at December 31, 2007
    1,913,468     $ 7 .49
 
The weighted average remaining contractual life for options outstanding and exercisable at December 31, 2007 was 8.4 years and 7.0 years, respectively.
 
The aggregate intrinsic value of outstanding options at December 31, 2007 was $66.2 million, of which $41.3 million related to exercisable options. The intrinsic value of options exercised was $24.6 million, $7.6 million and $1.6 million for the years ended December 31, 2007, 2006 and 2005, respectively. The weighted average fair value of stock options granted as part of the 2004 Plan was $16.58, $12.95 and $7.21 for the years ended December 31, 2007, 2006 and 2005, respectively.
 
Stock
Option Activity



 



The following table summarizes the activity of the
Company’s stock option plans:


 

































































































































































                 

 

 

 

 

 

Weighted



 

 

 

 

 

Average



 

 

Number of



 

 

Exercise



 

 

Options

 

 

Price
 


Outstanding, December 31, 2006


 

 

4,649,959

 

 

$

10

.03


Granted


 

 

2,071,819

 

 

$

27

.08


Exercised


 

 

(1,247,808

)

 

$

7

.39


Cancelled


 

 

(169,949

)

 

$

14

.05

 

 

 

 

 

 

 

 

 


Outstanding, December 31, 2007


 

 

5,304,021

 

 

$

17

.18

 

 

 

 

 

 

 

 

 


Exercisable at December 31, 2005


 

 

1,550,510

 

 

$

2

.54


Exercisable at December 31, 2006


 

 

1,953,502

 

 

$

4

.44


Exercisable at December 31, 2007


 

 

1,913,468

 

 

$

7

.49






 



The weighted average remaining contractual life for options
outstanding and exercisable at December 31, 2007 was
8.4 years and 7.0 years, respectively.


 



The aggregate intrinsic value of outstanding options at
December 31, 2007 was $66.2 million, of which
$41.3 million related to exercisable options. The intrinsic
value of options exercised was $24.6 million,
$7.6 million and $1.6 million for the years ended
December 31, 2007, 2006 and 2005, respectively. The
weighted average fair value of stock options granted as part of
the 2004 Plan was $16.58, $12.95 and $7.21 for the years ended
December 31, 2007, 2006 and 2005, respectively.


 




"Stock Option Activity" elsewhere:

Affymax (AFFY)
Dyax (DYAX)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki